IDEX Biometrics Reports Q1 2025 Revenues of $0.1M and Net Loss of $4.1M

Reuters
05-21
IDEX Biometrics Reports Q1 2025 Revenues of $0.1M and Net Loss of $4.1M

Idex Biometrics ASA has released its first quarter 2025 financial results, reporting revenues of $0.1 million during the quarter. The company experienced a net loss of $4.1 million. Ordinary operating expenses were registered at $2.4 million, and the cash balance as of 31 March 2025 was $1.1 million. Significant business updates include the announcement of a new strategy on 11 March 2025, aimed at transforming the market approach for its technology and products. Anders Storbråten has been appointed as the new CEO. The company has secured a new debt facility of NOK 30 million, which has been converted to shares, and successfully renegotiated its convertible bond with Heights. Operational improvements are underway, targeting a quarterly run rate for operating expenses between $1.5 million and $1.7 million by the end of Q3 2025. Additionally, Idex Biometrics received a production order in Japan from its manufacturing partner Beautiful Card Corporation, valued at approximately USD 50,000, and an order from DigAware for delivering biometric sensor solutions for access cards. The company also received an order for IDEX Pay biometric cards for VISA in the Middle East & Africa region, totaling 10,000 units. KONA I was granted a Mastercard Letter of Approval for IDEX Pay biometric cards. A subsequent offering was launched, allowing investors to participate under the same terms as shareholders involved in the debt conversion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Idex Biometrics ASA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001097965-en) on May 21, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10